Connor, Clark & Lunn Investment Management »

First Tracks Biotherapeutics shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.3M 165k 20.12